Fredric Kraemer MD
Dr. Fredric Kraemer is the Chief of the Division of Endocrinology, Gerontology and Metabolism. He is a board certified endocrinologist for over 35 years who specializes in the treatment diabetes mellitus, particularly type 1 diabetes, and the treatment of lipid disorders, such as elevated cholesterol or triglycerides.
Dr. Kraemer’s research career began with a focus on insulin resistance and glucose metabolism during which he contributed to some of the early studies utilizing insulin clamps and examining the effects of differences in the sources of carbohydrates on insulin and glucose responses in humans. Although continuing to be interested in insulin and glucose metabolism, the major focus of most of his research has been directed at understanding various aspects of cellular lipid metabolism. These studies have primarily focused on adipose tissue metabolism and, particularly, on lipid droplet formation and the regulation of lipid droplet hydrolysis leading to the release of fatty acids. He has had longstanding, productive collaborations with multiple members of the Stanford DRC, detailed below and in the proposal. Dr. Kraemer also serves on the SDRC Executive Committee.